Cell therapy weekly: Representatives reject 'right to try' and Duchenne trial placed on hold
This week: US House of Representatives votes against tabled 'right to try' bill and a new treatment for osteoarthritis receives RMAT designation.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.